What is the Difference Between Burkitt Lymphoma and Hodgkin Lymphoma?
🆚 Go to Comparative Table 🆚Burkitt lymphoma and Hodgkin lymphoma are both types of lymphoma, a cancer that affects the lymphatic system. However, there are several key differences between the two:
- Type of lymphocyte affected: Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that develops from B cells, while Hodgkin lymphoma is marked by the presence of Reed-Sternberg cells.
- Rate of growth: Burkitt lymphoma is a fast-growing (high-grade) lymphoma, whereas Hodgkin lymphoma tends to progress in a more predictable way.
- Age of diagnosis: The majority of non-Hodgkin lymphoma patients are over the age of 55 when first diagnosed, whereas the median age for diagnosis of Hodgkin lymphoma is 39.
- Gender distribution: Burkitt lymphoma is more common in males than females.
- Origin and location: Hodgkin lymphoma typically begins in the upper body, such as the neck, chest, or armpits, while non-Hodgkin lymphoma, including Burkitt lymphoma, may arise in lymph nodes anywhere in the body.
In terms of treatment, Burkitt lymphoma is usually treated with chemotherapy combined with antibody treatment rituximab, a combination known as chemo-immunotherapy. Hodgkin lymphoma, on the other hand, has a variety of treatment options, including chemotherapy, radiation therapy, and stem cell transplantation.
Comparative Table: Burkitt Lymphoma vs Hodgkin Lymphoma
Here is a table comparing the differences between Burkitt Lymphoma (BL) and Hodgkin Lymphoma (HL):
Feature | Burkitt Lymphoma | Hodgkin Lymphoma |
---|---|---|
Cell Type | Mature B-cell | B-cell, T-cell, or NK cell |
Aggressiveness | Aggressive | Can be indolent or aggressive |
Subtype | Non-Hodgkin Lymphoma | Can be either Hodgkin or non-Hodgkin |
Immunophenotype | CD19, CD20, and CD10 positive | Varies depending on subtype |
Molecular Features | t(8;14)(q24;q32), t(2;8)(p13;q24), and t(8;22)(q24;q11) are observed in almost all BL cases | Varies depending on subtype |
Burkitt Lymphoma is a mature B-cell non-Hodgkin lymphoma with an aggressive clinical course. The histologic hallmark of BL is a monomorphic proliferation of medium-sized lymphoma cells with a high proliferation rate. The neoplastic cells in BL usually express CD19, CD20, and CD10 and have specific molecular features such as t(8;14)(q24;q32), t(2;8)(p13;q24), and t(8;22)(q24;q11).
Hodgkin Lymphoma, on the other hand, can be either indolent or aggressive and is classified as a B-cell, T-cell, or NK cell lymphoma. The immunophenotype and molecular features of HL vary depending on the subtype.
- Hodgkin vs Non-Hodgkin Lymphoma
- Lymphoma vs Non Hodgkin’s Lymphoma
- Non Hodgkin’s Lymphoma vs Leukemia
- Lymphocytic Leukemia vs Lymphoma
- B Cell vs T Cell Lymphoma
- Leukemia vs Lymphoma
- Myeloma vs Lymphoma
- Lymphocyte vs Lymphoblast
- T Lymphocytes vs B Lymphocytes
- B Cell vs T Cell Leukemia
- Myeloblast vs Lymphoblast
- Thymoma vs Thymic Carcinoma
- Lymphoma vs Lymphedema
- Lymphadenopathy vs Lymphadenitis
- Lymphangitis vs Lymphadenitis
- Lymphocytes vs Leucocytes
- Leukemia vs Myeloma
- Bone Cancer vs Leukemia
- Myeloid vs Lymphoid Cells